The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
Open accessAbstract
Objective: Exosomes are nanovesicles that are released from normal and tumor cells and are detectable in cell culture supernatant and human biological fluids.Although previous studies have explored exosomes released from cancer cells, little is understood regarding the functions of exosomes released by normal cells.Natural killer (NK) cells display rapid immunity to metastatic or hematological malignancies, and efforts have been undertaken to clinically exploit the antitumor properties of NK cells.However, the characteristics and functions of exosomes derived from NK cells remain unknown.In this study, we explored NK cell-derived exosome-mediated antitumor effects against aggressive melanoma in vitro and in vivo.Methods: B16F10 cells were transfected with enhanced firefly luciferase (effluc) and thy1.1 genes, and thy1.1-positive cells were immunoselected using microbeads.The resulting B16F10/effluc cells were characterized using reverse transcriptase polymerase chain reaction (RT-PCR), western blotting, and luciferase activity assays.Exosomes derived from NK-92MI cells (NK-92 Exo) were isolated by ultracentrifugation and density gradient ultracentrifugation.NK-92 Exo were characterized by transmission electron microscopy and western blotting.We also performed an enzyme-linked immunosorbent assay to measure cytokines retained in NK-92 Exo cells.The in vitro cytotoxicity of NK-92 Exo against the cancer cells was determined using a bioluminescence imaging system (BLI) and CCK-8 assays.To investigate the possible side effects of NK-92 Exo on healthy cells, we also performed the BLI and CCK-8 assays using the human kidney Phoenix™-Ampho cell line.Flow cytometry and western blotting confirmed that NK-92 Exo induced apoptosis in the B16F10/effluc cells.In vivo, we used a B16F10/effluc cell xenograft model to detect the immunotherapeutic effect of NK-92 Exo.We injected NK-92 Exo into tumors, and tumor growth progression was monitored using the IVIS Lumina imaging system and ultrasound imaging.Tumor mass was monitored after in vivo experiments.Results: RT-PCR and western blotting confirmed effluc gene expression and protein levels in B16F10/effluc cells.B16F10/effluc activity was found to increase with increasing cell numbers, using BLI assay.For NK-92 Exo characterization, western blotting was performed on both ultracentrifuged and density gradient-isolated exosomes.The results confirmed that NK cell-derived exosomes express two typical exosome proteins, namely CD63 and ALIX.We demonstrated by western blot analysis that NK-92 Exo presented two functional NK proteins, namely perforin and FasL.Moreover, we confirmed the membrane expression of FasL.The enzyme-linked immunosorbent assay results indicated that NK-92 Exo can secrete tumor necrosis factor (TNF)-α, which affected the cell proliferation signaling pathway.The antitumor effect of NK-92 Exo against B16F10/effluc cells in vitro was confirmed by BLI (p < 0.001) and CCK-8 assays (p < 0.001).Furthermore, in normal healthy cells, even after 24 h of co-culture, NK-92 Exo did not exhibit significant side effects.In the in vivo experiments, tumors in the vehicle control group were significantly increased, compared with those in the NK-92 Exo-treated group (p < 0.05). Conclusion:The results of the current study suggest that exosomes derived from NK cells exert cytotoxic effects on melanoma cells and thus warrant further development as a potential immunotherapeutic strategy for cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., & Amigorena, S. (1998) · Nature Medicine · doi:10.1038/nm0598-594 · Cited by 2,266
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells
Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., Coscia, C., Iessi, E., Logozzi, M., Molinari, A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041152 · Cited by 1,555
Functional significance of the perforin/granzyme cell death pathway
Trapani, J. A., & Smyth, M. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri911 · Cited by 1,291
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,066
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011624 · Cited by 774
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
Katakowski, M., Buller, B., Zheng, X., Lu, Y., Rogers, T., Osobamiro, O., Shu, W., Jiang, F., & Chopp, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.019 · Cited by 681
Lee, J.-K., Park, S.-R., Jung, B.-K., Jeon, Y.-K., Lee, Y.-S., Kim, M.-K., Kim, Y.-G., Jang, J.-Y., & Kim, C.-W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084256 · Cited by 642
Self-citationDendritic cell-derived exosomes for cancer therapy.
Pitt, J. M., André, F., Amigorena, S., Soria, J.-C., Eggermont, A., Kroemer, G., & Zitvogel, L. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81137 · Cited by 636
Erdag, G., Schaefer, J. T., Smolkin, M. E., Deacon, D. H., Shea, S. M., Dengel, L. T., Patterson, J. W., & Slingluff, C. L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3218 · Cited by 590
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
Garbe, C., Eigentler, T. K., Keilholz, U., Hauschild, A., & Kirkwood, J. M. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0190 · Cited by 582
Malignant melanoma: genetics and therapeutics in the genomic era
Chin, L., Garraway, L. A., & Fisher, D. E. (2006) · Genes & Development · doi:10.1101/gad.1437206 · Cited by 511
Parkhurst, M. R., Riley, J. P., Dudley, M. E., & Rosenberg, S. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1347 · Cited by 475
Immune Surveillance Properties of Human NK Cell-Derived Exosomes
Lugini, L., Cecchetti, S., Huber, V., Luciani, F., Macchia, G., Spadaro, F., Paris, L., Abalsamo, L., Colone, M., Molinari, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101988 · Cited by 453
Satyamoorthy, K., Li, G., Gerrero, M. R., Brose, M. S., Volpe, P., Weber, B. L., Belle, P. A. V., Elder, D. E., & Herlyn, M. (2003) · PubMed · Cited by 426
Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
Klingemann, H., Boissel, L., & Toneguzzo, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00091 · Cited by 414
Functional significance of macrophage-derived exosomes in inflammation and pain
McDonald, M. K., Tian, Y., Qureshi, R. A., Gormley, M., Ertel, A., Gao, R., Aradillas Lopez, E., Alexander, G. M., Sacan, A., Fortina, P., et al. (2014) · Pain · doi:10.1016/j.pain.2014.04.029 · Cited by 319
Immunotherapy in melanoma: Recent advances and future directions
Franklin, C., Livingstone, E., Roesch, A., Schilling, B., & Schadendorf, D. (2017) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2016.07.145 · Cited by 278
Gao, W., Liu, H., Yuan, J., Wu, C., Huang, D., Ma, Y., Zhu, J., Ma, L., Guo, J., Shi, H., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12923 · Cited by 264
Müller, N., Michen, S., Tietze, S., Töpfer, K., Schulte, A., Lamszus, K., Schmitz, M., Schackert, G., Pastan, I., & Temme, A. (2015) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000082 · Cited by 253
Danesh, A., Inglis, H. C., Jackman, R. P., Wu, S., Deng, X., Muench, M. O., Heitman, J. W., & Norris, P. J. (2014) · Blood · doi:10.1182/blood-2013-10-530469 · Cited by 250
Bretz, N. P., Ridinger, J., Rupp, A.-K., Rimbach, K., Keller, S., Rupp, C., Marmé, F., Umansky, L., Umansky, V., Eigenbrod, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512806 · Cited by 245
Chen, X., Han, J., Chu, J., Zhang, L., Zhang, J., Chen, C., Chen, L., Wang, Y., Wang, H., Yi, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8526 · Cited by 242
Shah, N. N., Baird, K., Delbrook, C. P., Fleisher, T. A., Kohler, M. E., Rampertaap, S., Lemberg, K., Hurley, C. K., Kleiner, D. E., Merchant, M. S., et al. (2015) · Blood · doi:10.1182/blood-2014-07-592881 · Cited by 238
Hee Kim, S., Bianco, N., Menon, R., Lechman, E. R., Shufesky, W. J., Morelli, A. E., & Robbins, P. D. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.015 · Cited by 217
Baginska, J., Viry, E., Paggetti, J., Medves, S., Berchem, G., Moussay, E., & Janji, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00490 · Cited by 198
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas
Kruschinski, A., Moosmann, A., Poschke, I., Norell, H., Chmielewski, M., Seliger, B., Kiessling, R., Blankenstein, T., Abken, H., & Charo, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804788105 · Cited by 197
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
Cargnello, M., & Roux, P. P. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-12 · Cited by 173
In Vivo Cell Tracking with Bioluminescence Imaging
Kim, J. E., Kalimuthu, S., & Ahn, B.-C. (2015) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-014-0309-x · Cited by 160
Self-citationDamo, M., Wilson, D. S., Simeoni, E., & Hubbell, J. A. (2015) · Scientific Reports · doi:10.1038/srep17622 · Cited by 145
Cancer Immunotherapy via Dendritic Cells
Palucka, K., & Banchereau, J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_4 · Cited by 128
Klinker, M. W., Lizzio, V. A., Reed, T. J., Fox, D. A., & Lundy, S. K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00144 · Cited by 96
Wirtzfeld, L. A., Wu, G., Bygrave, M., Yamasaki, Y., Sakai, H., Moussa, M., Izawa, J. I., Downey, D. B., Greenberg, N. M., Fenster, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0414 · Cited by 94
Brodbeck, T., Nehmann, N., Bethge, A., Wedemann, G., & Schumacher, U. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-244 · Cited by 92
Expanded and armed natural killer cells for cancer treatment
Shimasaki, N., Coustan‐Smith, E., Kamiya, T., & Campana, D. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.06.013 · Cited by 90
Fais, S. (2012) · OncoImmunology · doi:10.4161/onci.22337 · Cited by 84
Kalimuthu, S., Gangadaran, P., Li, X. J., Oh, J. M., Lee, H., Jeong, S. Y., Lee, S., Lee, J., & Ahn, B. (2016) · Scientific Reports · doi:10.1038/srep30418 · Cited by 74
Self-citationStaals, R. H. J., & Pruijn, G. J. M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7841-7_11 · Cited by 69
A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer
Adumeau, P., Carnazza, K. E., Brand, C., Carlin, S. D., Reiner, T., Agnew, B. J., Lewis, J. S., & Zeglis, B. M. (2016) · Theranostics · doi:10.7150/thno.16744 · Cited by 67
Melanoma Cells Inhibit NK Cell Functions—Letter
Sconocchia, G., Arriga, R., Tornillo, L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1181 · Cited by 63
Three-dimensional ultrasound biomicroscopy for xenograft growth analysis
Cheung, A., Brown, A. S., Hastie, L. A., Cucevic, V., Roy, M. M., Lacefield, J. C., Fenster, A., & Foster, F. S. (2005) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2005.03.003 · Cited by 60
The potential of exosomes in immunotherapy of cancer
Chaput, N., Taïeb, J., Schartz, N. E. C., Flament, C., Novault, S., André, F., & Zitvogel, L. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.05.009 · Cited by 52
Ames, E., Hallett, W. H. D., & Murphy, W. J. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03818.x · Cited by 48
Oba, J., Nakahara, T., Abe, T., Hagihara, A., Moroi, Y., & Furue, M. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.02.011 · Cited by 45
Melanoma immunoediting by NK cells
Balsamo, M., Pietra, G., Vermi, W., Moretta, L., Mingari, M. C., & Vitale, M. (2012) · OncoImmunology · doi:10.4161/onci.21456 · Cited by 18
Cited by
Exosome-Mediated Metastasis: Communication from a Distance
Wortzel, I., Dror, S., Kenific, C. M., & Lyden, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.011 · Cited by 1,285
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Exosome-Based Cell-Cell Communication in the Tumor Microenvironment
Maia, J., Caja, S., Strano Moraes, M. C., Couto, N., & Costa-Silva, B. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00018 · Cited by 666
Exosomes─Nature’s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics
Tenchov, R., Sasso, J. M., Wang, X., Liaw, W.-S., Chen, C.-A., & Zhou, Q. A. (2022) · ACS Nano · doi:10.1021/acsnano.2c08774 · Cited by 604
Meng, W., He, C., Hao, Y., Wang, L., Li, L., & Zhu, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748758 · Cited by 592
Metadata
- Authors
- Zhu, L., Kalimuthu, S., Gangadaran, P., Oh, J. M., Lee, H. W., Baek, S. H., Jeong, S. Y., Lee, S.-W., Lee, J., & Ahn, B.-C.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 7
- Issue
- 10
- Pages
- 2732-2745
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2734802465
- Cited by
- 471
- References
- 50
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.